Oncolytics Biotech buy Royal Bank of Canada
Start price
10.03.25
/
50%
€1.61
Target price
10.03.26
€4.60
Performance (%)
-
End price
11.03.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncolytics Biotech | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Royal Bank of Canada from $6.00 to $5.00. They now have an "outperform" rating on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten